Neither Wegovy nor Ozempic, which also contains semaglutide but is licensed to help people with diabetes manage their blood sugar (it is frequently used off-label for weight loss), are approved for sale in India and Novos India Managing Director Vikrant Shrotriya told Reuters the company is planning to officially launch Wegovy in the country in 2026, admitting that it is difficult to trace illegal sellers in India
They work by targeting areas of the brain that regulate appetite and food intake
For diabetics, it lowers HbA1c by up to 2.4%, improves insulin sensitivity, and reduces the risk of progression to type 2 diabetes by up to 94% in those with prediabetes
Lastly, even though we provided dietary and exercise counseling to all participants, energy intake and physical activity were not measured, which may be a confounding factor of interindividual variability in weight loss between groups
During the first 4-8 weeks, many patients experience initial fatigue as their bodies adjust to reduced caloric intake and medication effects
Tirzepatide access is growing, but coverage may vary
